|
|
| MRD / Regn No. |
: 20220000593 |
Date |
: 24/06/2026 |
| Patient Name |
: Sarveswaran Thiruprathangan |
Age & Gender |
: 62 Yrs. / Male |
| Contact No. |
: 9941161113 |
UHID |
: |
| Ht / Wt / BMI |
: 159.5 / 63.3 / 24.88 |
BP S / BP D |
: 135 / 76 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (02/Jun/2002) | BENIGN PROSTATIC HYPERPLASIA (17/Nov/2022) | |
|
Subjective |
: |
FOLLOW UP VISIT |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM WELL CONTROLLED |
|
Plan |
: |
INCREASE SEMAGLUTIDE TO 1 MG,DECREASE INSULIN TO 18-01-2 UNITS |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 106 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 101 mg/dL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
18-0-12 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
TABLET DAPAGLIFLOZIN 10 MG PIOGLITAZONE 15 MG
UDAPA PRO
Medicine For DIABETES MASLD |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE GU INFECTIONS AND FEET SWELLING | |
|
3 |
INJECTION SEMAGLUTIDE 1 MG
SEMASIZE 1 MG
Medicine For DIABETES OBESITY HEART PROTECTION |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING OR VISUAL DISTURBANCE | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 24/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP HBA1C |
| |
|
| |
|
